IRIDEX CorpNASDAQ:IRIX
- LAST PRICE1.7200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.7000/ 10
- Ask / Lots2.0500/ 1
- Open / Previous Close--- / 1.7200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IRIX |
|---|---|---|
| 09:50 ET | 100 | 1.73 |
| 10:04 ET | 100 | 1.7256 |
| 10:56 ET | 200 | 1.75 |
| 12:32 ET | 1000 | 1.75 |
| 01:04 ET | 300 | 1.75 |
| 02:20 ET | 100 | 1.7803 |
| 02:45 ET | 2119 | 1.75 |
| 03:42 ET | 941 | 1.74 |
| 03:48 ET | 4241 | 1.71 |
| 04:00 ET | 835 | 1.72 |
Nov 19, 2024
Iridex Comments on Changing Glaucoma Reimbursement Landscape, from 8:14AM ET on Tuesday Nov 19, 2024 by Dow Jones
8:14AM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 12, 2024
Iridex Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones*DJ Iridex 3Q Loss/Shr 12c >IRIX, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 4, 2024
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024, from 4:05PM ET on Monday Nov 04, 2024 by Dow Jones
4:05PM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IRIDEX Corp | 28.6M | -2.5x | --- |
BIOLASE Inc | 183.0K | 0.0x | --- |
Owlet Inc | 69.5M | -2.7x | --- |
ETAO International Co Ltd | 1.5K | 0.0x | --- |
908 Devices Inc. | 95.0M | -1.5x | --- |
Bionano Genomics Inc | 17.7M | -0.1x | --- |
Company Information
IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Contact Information
- Headquarters
- 1212 Terra Bella AveMOUNTAIN VIEW, CA, United States 94043-1824
- Phone
- 650-940-4700
- Fax
- 650-940-4710
Executives
- Executive Chairman of the Board
- Scott Shuda
- President, Chief Executive Officer, Chief Operating Officer
- Patrick Mercer
- Interim Chief Financial Officer
- Fuad Ahmad
- Independent Director
- Nandini Devi
- Independent Director
- Robert Grove
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $28.6M |
|---|---|
Revenue (TTM) | $48.4M |
Shares Outstanding | 16.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.80 |
EPS | $-0.68 |
Book Value | $0.59 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -22.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
